Digital News and Views

Cancer Support blog graphics

Cancer Support: Surrounded by Water without a Drop to Drink, so it Seemed

Carly* knew her life was about to change when she woke up one morning and found a painful lump in one of her breasts. She recalls telling herself all of the possible things the lump could be—what she hoped they would be—that didn’t involve the “C” word; the “C” word being cancer. “I knew at that moment, deep down, that my life was going to change forever,” she confesses. Carly’s Read more [...]

The Race to the Cure-blog art

The Future of Hepatitis C Treatment is becoming a Reality

The race to the hepatitis C cure took an exciting turn this month and the future of treatment became a reality for some patients battling the virus. Drug manufacturer, Gilead Sciences, received FDA approval to market its once-daily single tablet regimen for treatment of chronic hepatitis C genotype 1 in adults. Gilead’s new drug Harvoni®, considered by some clinicians as a one-two punch in stopping Read more [...]

hepatitis c drug pipeline

The Race to the Cure Continues: 2014 Promises More Hepatitis C Treatment Options

  This year, 2014, has indeed proven to be an exciting one for the advancement of chronic hepatitis C (CHC) genotype 1 treatment. This month, we saw the FDA approval of Gilead’s new drug Harvoni®, a once-daily single tablet regimen for treatment of chronic HCV genotype 1 in adults. HCV genotype 1 is the main subtype of the virus effecting about 70 percent of cases in the U.S. Harvoni Read more [...]

Otezla blog

Axium Healthcare Pharmacy to begin Dispensing Otezla®: the First and only FDA Approved PDE4 Inhibitor for the Treatment of Plaque Psoriasis

Lake Mary, FLA – Axium Healthcare Pharmacy announced today that it will begin to dispense Otezla® (apremilast), an oral treatment for moderate to severe plaque psoriasis in patients where phototherapy or systemic therapy is deemed appropriate. Otezla® is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, a chronic inflammatory skin disease that involves the immune Read more [...]

BCSM blog

Breast Cancer Support: Social Media Twitter Chat, #BCSM

Are you looking for support after a breast cancer diagnosis? Are you looking for support years after that diagnosis? Are you a caregiver or loved one looking for others with similar experiences in supporting a person with a breast cancer diagnosis? Finding that support is as easy as joining Twitter. Weekly Breast Cancer Twitter Chat Since July 4, 2011, a Tweetchat (Twitter Chat) called #BCSM Read more [...]

Axium-Guidebook2 blog

The 1-2-3 Approach to Hepatitis C Therapy Management

Some things in life are easy. Hepatitis C is not one of them. But wouldn’t it be easier if one could see the future of HCV therapy management? Axium Healthcare Pharmacy thinks so, and through the research of noted pharmacist Tina Valbh B.S Pharm., Rph, has developed a groundbreaking and easy-to-digest briefing on The Future of HCV. Part of the FREE three-part HCV white paper series from Read more [...]

Category: Pressroom

Patients 1st: The e-patient’s Bill of Rights and Responsibilities

We are part of a movement to Equip, Enable, Empower and Engage patients: the drive for participatory medicine. e-Patients are defined by Tom Ferguson, MD as medical consumers who are “equipped, empowered and engaged” in their own healthcare initiatives. And, they are now part of the healthcare equation. That means the patient perspective on healthcare is being recognized and valued. Providing Read more [...]

Axium-specialty pharmacy medications

Managing the Specialty Pharmacy Growth Spurt

It's no secret that demand for specialty pharmacy products and services is growing at an unprecedented rate. Right now, specialty pharmacy medications represent approximately 40% of the U.S. drug market. It won't be long before we see specialty medications reach or even pass the 50% mark. Specialty Pharmacy Challenges This type of growth presents unique challenges to specialty pharmacies. As chronic Read more [...]

AASLD, EASL, WHO Guidelines

AASLD, EASL, and WHO Guidelines Overview for Hepatitis C Management

In recent months, new next-generation direct-acting antiviral (DAA) drugs have been released for the treatment of the hepatitis C virus (HCV). These landmark treatments include all-oral drugs sofosbuvir (brand name Sovaldi) and simeprevir (brand name Olysio). New HCV treatments have drastically changed the way patients are receiving treatment while significantly improving patient outcomes. To incorporate Read more [...]

Axium-Annual Meeting & Expo

Axium Announced as Platinum Sponsor for NASP / SPAARx Annual Meeting & Expo

Meeting participants gain valuable insights, make new business connections, earn continuing education (CE) credits and enjoy learning from colleagues at the meeting. TAMPA, FL (August 26, 2014) —The National Association of Specialty Pharmacy (NASP) / Specialty Pharmacy Association of America (SPAARx) announced today that Axium Healthcare Pharmacy has become a platinum-level sponsor for the Read more [...]